These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7016920)

  • 1. A factor X-activating cysteine protease from malignant tissue.
    Gordon SG; Cross BA
    J Clin Invest; 1981 Jun; 67(6):1665-71. PubMed ID: 7016920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.
    Falanga A; Gordon SG
    Biochemistry; 1985 Sep; 24(20):5558-67. PubMed ID: 3935163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cysteine proteinase procoagulant from amnion-chorion.
    Gordon SG; Hasiba U; Cross BA; Poole MA; Falanga A
    Blood; 1985 Dec; 66(6):1261-5. PubMed ID: 3933592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A proteolytic procoagulant associated with malignant transformation.
    Gordon SG
    J Histochem Cytochem; 1981 Mar; 29(3A Suppl):457-63. PubMed ID: 7016982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
    Falanga A; Bolognese Dalessandro AP; Casali B; Roncaglioni MC; Donati MB
    Int J Cancer; 1987 Jun; 39(6):774-7. PubMed ID: 3294610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of properties of cancer procoagulant and human amnion-chorion procoagulant.
    Falanga A; Gordon SG
    Biochim Biophys Acta; 1985 Sep; 831(1):161-5. PubMed ID: 3899178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor X-activating procoagulant in normal and malignant breast tissue.
    el-Baruni K; Taylor I; Roath S; Francis JL
    Hematol Oncol; 1990; 8(6):323-32. PubMed ID: 2286355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight factor X activator from Cerastes vipera (Sahara sand viper) venom.
    Farid T; Nasser H; Zaki K; el-Asmar MF
    Toxicon; 1993 Aug; 31(8):1007-17. PubMed ID: 8212040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer procoagulant--CP.
    Rucińska M; Gacko M; Skrzydlewski Z
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():110-7. PubMed ID: 9337529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemistry of cancer procoagulant.
    Mielicki WP
    Haemostasis; 2001; 31 Suppl 1():8-10. PubMed ID: 11990487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different expression of procoagulant activity in human cancer cells cultured "in vitro" or in cells isolated from human tumor tissues.
    Zucchella M; Pacchiarini L; Tacconi F; Saporiti A; Grignani G
    Thromb Haemost; 1993 Apr; 69(4):335-8. PubMed ID: 8497845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
    Kaplinska K; Rozalski M; Krajewska U; Mielicki WP
    Thromb Res; 2009 Jul; 124(3):364-7. PubMed ID: 19419757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
    Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor X-activating activity from Guerin epithelioma.
    Mielicki W; Wierzbicki R
    Neoplasma; 1988; 35(3):279-84. PubMed ID: 3405336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endotoxin-induced procoagulant of mouse exudate macrophages: a factor-X activator.
    Shands JW
    Blood; 1983 Aug; 62(2):333-40. PubMed ID: 6871467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant.
    Roncaglioni MC; Dalessandro AP; Casali B; Vermeer C; Donati MB
    Haemostasis; 1986; 16(3-4):295-9. PubMed ID: 3530904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The site of activation of factor X by cancer procoagulant.
    Gordon SG; Mourad AM
    Blood Coagul Fibrinolysis; 1991 Dec; 2(6):735-9. PubMed ID: 1799660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The purification and properties of cancer procoagulant from murine tumors.
    Moore WR
    Biochem Biophys Res Commun; 1992 Apr; 184(2):819-24. PubMed ID: 1575750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteine protease characteristics of the proteoglycanase activity from normal and pseudoxanthoma elasticum (PXE) fibroblasts.
    Gordon SG; Hinkle LL; Shaw E
    J Lab Clin Med; 1983 Sep; 102(3):400-10. PubMed ID: 6350511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.
    Ogiichi T; Hirashima Y; Nakamura S; Endo S; Kurimoto M; Takaku A
    J Neurooncol; 2000; 46(1):1-9. PubMed ID: 10896200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.